GlassScriptPhysician profile
Lana E Turk
NPI 1548262686
$1,107.95
in general payments reported to CMS, 2019-2025
18 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $15.50 · 2021: $88.44 · 2022: $77.01 · 2023: $90.16 · 2024: $363 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.10 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $225.45 | 2025 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $172.08 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.54 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $93.41 | 2023-2024 | Veozah |
| Amgen INC. | $92.85 | 2022-2024 | Repatha, Otezla |
| Pfizer INC. | $81.31 | 2019-2024 | |
| Lilly USA, LLC | $71.02 | 2022-2024 | Mounjaro, Jardiance |
| Abbott Laboratories | $66.23 | 2021-2024 | Freestyle Libre 3 |
| Kowa Pharmaceuticals America, INC. | $32.98 | 2021 | |
| Philips North America LLC | $24.48 | 2019 | |
| Axonics, INC. | $21.51 | 2024 | Axonics |
| Medtronic, INC. | $21.20 | 2023 | Intellis Adaptivestim |
| Glaxosmithkline, LLC. | $21.16 | 2024 | Trelegy Ellipta, Arexvy |
| Nevro Corp. | $20.50 | 2022 | |
| Saluda Medical Americas, INC. | $18.75 | 2024 | Evoke |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $16.70 | 2022 | |
| Boston Scientific Corporation | $15.50 | 2020 | |
| Amarin Pharma, INC. | $14.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lana Turk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.